Aim: We review clinical characteristics, diagnostic difficulties, and our experience in the surgical management of ovarian fibromas. Method: Twenty-three women with the operative diagnosis of an ovarian fibroma managed between January 1995 and August 2004 were reviewed retrospectively. Results: These patients comprised 1% of all benign ovarian tumors seen over this study period. The median age was 45 years, and 11 patients (47.8%) were postmenopausal. The main presenting symptom was abdominal pain (43.5%). The diagnosis of an ovarian fibroma or a solid ovarian tumor was correctly made preoperatively in only 5 patients (21.7%). All patients underwent surgical treatment: 18 by laparotomy and 5 by laparoscopy. All tumors were unilateral, and the median size was 13 cm. Fourteen patients underwent conservative surgery, and 9 had total abdominal hysterectomy with bilateral salpingo-oophorectomy. Two cases of fibrosarcoma were reviewed on the final pathology. Conclusions: Gynecologists should be aware of this group of ovarian tumors despite their uncommon occurrence. There are clinical clues to differentiate an ovarian fibroma from uterine fibroid and ovarian malignancy. Surgical removal of these solid ovarian tumors is recommended because of the low probability of malignancy. Minimal-access surgery is an option, especially when the tumor is of moderate or small size.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.